Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin like with PHD and ring finger domains 2 pseudogene 1 (UHRF2P1) is a human pseudogene located on the genome, annotated in databases such as NCBI Gene (ID: 260337)[3][5]. Pseudogenes are DNA sequences that resemble known genes but lack coding potential due to mutations or truncations, and they do not produce a functional protein[1]. Although some pseudogenes can be transcribed and may have a regulatory impact on their parent gene or other genes—such as acting as microRNA decoys or through the generation of regulatory RNAs—UHRF2P1 is not known to code for a protein or function as a therapeutic target. Its "parent" functional gene, UHRF2, is a multidomain regulatory protein implicated in chromatin regulation and DNA methylation pathways, but UHRF2P1 itself has no known direct biological function, druggability, or therapeutic relevance[3][5][1]. There are no drugs, clinical biomarkers, or safety/toxicity data associated with UHRF2P1. Pseudogenes generally are not considered valid therapeutic targets, and there is no evidence that UHRF2P1 deviates from this rule[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin like with PHD and ring finger domains 2 pseudogene 1 (UHRF2P1).